Skip to content

Clinical trials

Expanded access Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Expanded access Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available15
Approved for marketing7
Available6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jonsson Comprehensive Cancer Center2
AVM Biotechnology Inc1
Agenus Inc.1
Andrei Iagaru1
Aragon Pharmaceuticals, Inc.1
AstraZeneca1
Aveni Foundation1
Bayer1
Dana Mathews1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms28
Pancreatic Neoplasms5
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Ovarian Neoplasms4
Colorectal Neoplasms3
Sarcoma3
Carcinoma, Renal Cell2
Melanoma2
Brain Neoplasms1

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.